Tarsons Products Limited (NSE:TARSONS)
344.95
+7.65 (2.27%)
Aug 21, 2026, 3:30 PM IST
Tarsons Products Market Cap
Tarsons Products has a market cap or net worth of 18.35 billion as of August 21, 2026. Its market cap has increased by 4.55% in one year.
Market Cap
18.35B
Enterprise Value
22.03B
Revenue
4.41B
Ranking
n/a
PE Ratio
166.34
Stock Price
344.95
ChartMarket Cap Chart
Since November 26, 2021, Tarsons Products's market cap has decreased from 43.54B to 18.35B, a decrease of -57.85%. That is a compound annual growth rate of -16.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 18.35B | 47.86% |
| Dec 31, 2025 | 12.41B | -42.20% |
| Dec 31, 2024 | 21.48B | -24.21% |
| Dec 29, 2023 | 28.34B | -23.31% |
| Dec 30, 2022 | 36.95B | 7.67% |
| Dec 31, 2021 | 34.32B | -21.19% |
| Nov 26, 2021 | 43.54B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.56T |
| Divi's Laboratories | 2.28T |
| Apollo Hospitals Enterprise | 1.25T |
| Cipla | 1.16T |
| Indoco Remedies | 20.89B |
| Windlas Biotech | 20.50B |
| Sakar Healthcare | 20.31B |
| Krsnaa Diagnostics | 18.22B |